Timothy M Mayleben Esperion Therapeutics, Inc. (ESPR) insider trading activity

ESPR Quotes by TradingView

Timothy M Mayleben is President & CEO of Esperion Therapeutics, Inc.. Currently has a direct ownership of 122,698 shares of ESPR, which is worth approximately $315,333. The most recent transaction as insider was on Dec 30, 2020, when has been sold 10,700 shares (Common Stock) at a price of $2.1 per share, resulting in proceeds of $22,470. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 123K
0% 3M change
0% 12M change
Total Value Held $315,333

TIMOTHY M MAYLEBEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 30 2020
BUY
Exercise of conversion of derivative security
$22,470 $2.1 p/Share
10,700 Added 8.02%
122,698 Common Stock

Also insider at

MRNS
MARINUS PHARMACEUTICALS, INC. Healthcare
LABP
Landos Biopharma, Inc. Healthcare
TMM

Timothy M Mayleben

President & CEO
Ann Arbor, MI

Track Institutional and Insider Activities on ESPR

Follow Esperion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ESPR shares.

Notify only if

Insider Trading

Get notified when an Esperion Therapeutics, Inc. insider buys or sells ESPR shares.

Notify only if

News

Receive news related to Esperion Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ESPR